163 related articles for article (PubMed ID: 33186140)
21. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
22. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
[TBL] [Abstract][Full Text] [Related]
23. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials.
Zhu J; Zhang Z; Bian D; Chen Q; Hu Q; Ji S; Gu K
Medicine (Baltimore); 2020 Jan; 99(1):e18663. PubMed ID: 31895831
[TBL] [Abstract][Full Text] [Related]
24. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
[TBL] [Abstract][Full Text] [Related]
25. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
[TBL] [Abstract][Full Text] [Related]
26. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy.
Li X; Li L; Sun R; Gao J; Li Z; Xue Y; Zhu L; Xu T; Sun C; Xi Y; Xiong W
Eur J Med Res; 2023 Oct; 28(1):399. PubMed ID: 37794519
[TBL] [Abstract][Full Text] [Related]
27. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
28. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
29. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
Keys HM; Bundy BN; Stehman FB; Muderspach LI; Chafe WE; Suggs CL; Walker JL; Gersell D
N Engl J Med; 1999 Apr; 340(15):1154-61. PubMed ID: 10202166
[TBL] [Abstract][Full Text] [Related]
31. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
32. Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.
Chou HH; Huang HJ; Lin H; Yang LY; Hsueh S; Liu FY; Liou YL; Liou JD; Chen MY; Chao A; Lin G; Chang TC; Lai CH
Am J Clin Oncol; 2017 Jun; 40(3):241-249. PubMed ID: 25350466
[TBL] [Abstract][Full Text] [Related]
33. Completing or Abandoning Radical Hysterectomy in Early-Stage Lymph Node-Positive Cervical Cancer: Impact on Disease-Free Survival and Treatment-Related Toxicity.
Derks M; Groenman FA; van Lonkhuijzen LRCW; Schut PC; Westerveld H; van der Velden J; Kenter GG
Int J Gynecol Cancer; 2017 Jun; 27(5):1015-1020. PubMed ID: 28498252
[TBL] [Abstract][Full Text] [Related]
34. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
35. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
36. Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB-IIA cervical cancer patients.
Lee KB; Kim YS; Lee JM
J Gynecol Oncol; 2018 Jan; 29(1):e5. PubMed ID: 29185263
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial.
Wang X; Shen Y; Zhao Y; Li Z; Gou H; Cao D; Yang Y; Qiu M; Li Q; Liu J; Yi C; Liao Z; Luo D; Xu F; Bi F
Eur J Surg Oncol; 2015 Aug; 41(8):1082-8. PubMed ID: 26033265
[TBL] [Abstract][Full Text] [Related]
38. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Oh YT; Kang SH
BMC Cancer; 2017 Apr; 17(1):297. PubMed ID: 28454573
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
